Shu Lian
- Molecular Biology
- Biomedical Engineering top 10%
- Oncology top 10%
- Immunology
- Cancer Research top 10%
- Topics
- Cancer Cells and Metastasis (7 papers)Nanoplatforms for cancer theranostics (5 papers)Extracellular vesicles in disease (4 papers)
- Partner nations
- ChinaSwitzerlandRussia
In The Last Decade
Shu Lian
24 papers receiving 825 citations
Peers
Comparison fields: 5 of 84
- Molecular Biology 378
- Biomedical Engineering 266
- Oncology 238
- Immunology 199
- Cancer Research 169
Countries citing papers authored by Shu Lian
This map shows the geographic impact of Shu Lian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shu Lian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shu Lian more than expected).
Fields of papers citing papers by Shu Lian
This network shows the impact of papers produced by Shu Lian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shu Lian. The network helps show where Shu Lian may publish in the future.
Co-authorship network of co-authors of Shu Lian
This figure shows the co-authorship network connecting the top 25 collaborators of Shu Lian. A scholar is included among the top collaborators of Shu Lian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shu Lian. Shu Lian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 1 | |
| 3 | 25 | |
| 4 | 10 | |
| 5 | 19 | |
| 6 | 2 | |
| 7 | 47 | |
| 8 | 87 | |
| 9 | 57 | |
| 10 | 104 | |
| 11 | 66 | |
| 12 | 25 | |
| 13 | 41 | |
| 14 | 13 | |
| 15 | 26 | |
| 16 | 1 | |
| 17 | 28 | |
| 18 | 18 | |
| 19 | 146 | |
| 20 | 60 |
About Shu Lian
Shu Lian is a scholar working on Cancer Research, Biochemistry and Oncology, having authored 24 papers that have together received 828 indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (7 papers), Nanoplatforms for cancer theranostics (5 papers) and Extracellular vesicles in disease (4 papers). The work is most often cited by research in Biomaterials (148 citations), Cancer Research (169 citations) and Immunology (199 citations). Shu Lian has collaborated with scholars based in China, Switzerland and Russia. Frequent co-authors include Lee Jia, Yusheng Lu, Xiaodong Xie, Bifei Li, Yu Gao, Yunlong Cheng, Fengqiao Li, Shuhui Li, Hang Lin and Huijuan Zhang. Their work appears in journals such as Nature Communications, Cancer and Chemical Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.